Show simple item record Odler, Balázs Ivancsó, István Somogyi, V Benke, Kálmán Tamási, Lilla Gálffy, Gabriella Szalay, Balázs Müller, Veronika 2019-11-25T07:52:14Z 2019-11-25T07:52:14Z 2015
dc.identifier 84942777657
dc.identifier.citation journalVolume=10;journalIssueNumber=1;journalTitle=INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE;pagerange=2017-2025;journalAbbreviatedTitle=INT J CHRONIC OBSTR;
dc.identifier.uri doi:10.2147/COPD.S91654
dc.description.abstract INTRODUCTION: The association between vitamin D and clinical parameters in obstructive lung diseases (OLDs), including COPD and bronchial asthma, was previously investigated. As asthma-COPD overlap syndrome (ACOS) is a new clinical entity, the prevalence of vitamin D levels in ACOS is unknown. AIM: Our aim was to assess the levels of circulating vitamin D (25-hydroxyvitamin D [25(OH)D]) in different OLDs, including ACOS patients, and its correlation with clinical parameters. METHODS: A total of 106 men and women (control, n=21; asthma, n=44; COPD, n=21; and ACOS, n=20) were involved in the study. All patients underwent detailed clinical examinations; disease control and severity was assessed by disease-specific questionnaires (COPD assessment test, asthma control test, and modified Medical Research Council); furthermore, 25(OH)D levels were measured in all patients. RESULTS: The 25(OH)D level was significantly lower in ACOS and COPD groups compared to asthma group (16.86+/-1.79 ng/mL and 14.27+/-1.88 ng/mL vs 25.66+/-1.91 ng/mL). A positive correlation was found between 25(OH)D level and forced expiratory volume in 1 second (r=0.4433; P<0.0001), forced vital capacity (FVC) (r=0.3741; P=0.0004), forced expiratory flow between 25% and 75% of FVC (r=0.4179; P<0.0001), and peak expiratory flow (r=0.4846; P<0.0001) in OLD patient groups. Asthma control test total scores and the 25(OH)D level showed a positive correlation in the ACOS (r=0.4761; P=0.0339) but not in the asthma group. Higher COPD assessment test total scores correlated with decreased 25(OH)D in ACOS (r=-0.4446; P=0.0495); however, this was not observed in the COPD group. CONCLUSION: Vitamin D deficiency is present in ACOS patients and circulating 25(OH)D level may affect disease control and severity.
dc.format.extent 2017-2025
dc.relation.ispartof urn:issn:1176-9106
dc.title Vitamin D deficiency is associated with impaired disease control in asthma-COPD overlap syndrome patients
dc.type Journal Article 2019-09-02T09:22:46Z
dc.language.rfc3066 en
dc.rights.holder NULL
dc.identifier.mtmt 2973023
dc.identifier.wos 000362298700001
dc.identifier.pubmed 26451099
dc.contributor.department SE/AOK/I/Laboratóriumi Medicina Intézet
dc.contributor.department SE/AOK/K/Pulmonológiai Klinika
dc.contributor.institution Semmelweis Egyetem

Files in this item

This file is available only from Semmelweis network


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account